The city of Lexington, Kentucky, currently has 1 active clinical trials seeking participants for Amyotrophic Lateral Sclerosis research studies.
Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients
Recruiting
The objective is to compare the efficacy and safety of masitinib in combination with riluzole versus matched placebo in combination with riluzole for the treatment of Amyotrophic Lateral Sclerosis (ALS).
Gender:
All
Ages:
Between 18 years and 81 years
Trial Updated:
04/14/2023
Locations: University of Kentucky, Lexington, Kentucky
Conditions: Amyotrophic Lateral Sclerosis